Journal List > Perinatology > v.29(3) > 1102101

Cho, Sim, Kim, Hong, Ahn, Hong, Oh, and Kim: Maternal Smoke during Pregnancy Programs for Bone Disturbance in Offspring

Abstract

Objective

A number of epidemiological studies have reported that smoking causes a decrease in bone mineral density (BMD) and an increase in the risk of bone fracture, and is a risk factor for osteoporosis. Maternal smoking during pregnancy results in a variety of adverse developmental outcomes associated with intrauterine growth restriction. However, little is known about the effect of maternal smoking during pregnancy on BMD in the offspring.

Methods

Pregnant CD-1 mice were exposed to cigarette smoke (1 or 2 cigarettes/day, 5 days/week) (smoke group) or sham exposed (control group) throughout pregnancy. After delivery, nursing dams and offspring were kept together in individual cages. At 4 weeks, the fourth lumbar vertebral body of each offspring was scanned with a micro- computed tomography apparatus. Trabecular parameters including bone volume fraction (bone volume/total volume, %), thickness (mm), number (1/mm), and separation (mm) were evaluated. The BMD was also measured.

Results

No differences in the trabecular bone volume fraction, thickness, separation, and number and the BMD were observed between the offspring of the control and 1 cigarette smoking dams. However, trabecular bone volume fraction, thickness, number, and the BMD were significantly lower, whereas trabecular separation was higher in the offspring of 2 cigarette smoking dams compared with those of the offspring from control dams.

Conclusion

Maternal smoking during pregnancy decreased BMD and altered bone microarchitecture in the offspring. These results will become a great source to inform the importance of quitting smoking during pregnancy.

Introduction

Cigarette smoking is one of the primary causes of increased health-care costs and decreased life expectancy.12 Epidemiological studies have focused on the deleterious effects of smoking on human health. In particular, a number of epidemiological studies reported that cigarette smoke decreases bone mineral density (BMD), increases the risk of bone fracture, and is a risk factor for osteoporosis.345 In the United States, the prevalence of maternal smoking during pregnancy decreased slightly from 13.3% in 2000 to 12.3% in 2010. However, the smoking rate among pregnant women is still high at over 10%.6 In Korea, 3% of all women smoke during pregnancy.7 Maternal smoking during pregnancy can cause various problems such as an increased chance of premature birth, placental abruption, and placenta previa. Furthermore, it can affect the health of the fetus by increasing the risks of intrauterine fetal growth restriction and sudden infant death syndrome.8
Despite extensive research on maternal smoking during pregnancy, the exact effect of maternal smoking during pregnancy on the bones of the offspring remains unknown. One study reported low bone mineral content and BMD in the newborns of mothers who smoked.9 Another study that examined the long-term effects of maternal smoking during pregnancy showed that smoking has negative effects on child bone mass for 8 years.10 On the other hand, other studies reported that maternal smoking during pregnancy does not affect bone mineral content and BMD in the neonate.11 Therefore, further studies are needed to evaluate the effects of maternal smoking on the offspring's bones. The aim of the present study was to evaluate the effect of maternal smoking during pregnancy on the bones of the offspring.

Methods

1. Animals

CD-1 outbred mice were purchased from Charles River Laboratories (Charles River Laboratories, Wilmington, MA, USA) and maintained under conditions of 14 hours light, 10 hours dark at 23℃ with food and water available ad libitum. Experimental pregnant mice were obtained after mating. Day 1 of gestation (E1) was designated the first day after observation of the vaginal plug, which is formed by secretions from the male vesicular and coagulating glands and is a convenient and easily visible indicator that mating has occurred. Coeval pregnant mice were to check the health condition at all stages of the experiment. All animal procedures were approved by the Korea University Animal Ethics Committee (KUIACUC- 2012-121).

2. Exposure to cigarette smoke

Pregnant mice were randomly divided into three groups: a non-exposed group, which included control pregnant mice that received no intervention; a 1 cigarette exposed group, which included pregnant mice that were exposed individually to the smoke of 1 cigarette/day during delivery; and a 2 cigarette exposed group, which included pregnant mice that were exposed individually to the smoke of 2 cigarettes/day during pregnancy. Five pregnant mice were studied in each group. Pregnant mice in the 1 cigarette or 2 cigarette groups were exposed to 1 or 2 cigarettes per day for 5 days/week, respectively (code 3R4F reference cigarettes, produced for the University of Kentucky Tobacco and Health Research Institute, Lexington, KY, USA) from E1 to delivery. On each day of exposure, animals were placed individually inside a Plexiglas cabinet (40×90×100 mm). Cigarette smoke was delivered into the cabinet through air inflow at a rate of 1.7 mL/s by introducing a burning cigarette in the chamber; the combustion time of the cigarette was less than 3 minutes. For 2 cigarette group, cigarette smoke was delivered with no resting time between two cigarettes.
A ventilator inside the cabinet ensured rapid and equal distribution of smoke. Fresh air was delivered into the cabinet to remove the smoke. The control, non-exposed group was placed in an identical chamber and then exposed to inflow of fresh air for the same period.

3. Micro-computed tomography (CT) analysis

After delivery, nursing dams and offspring were kept together in individual cages for 4 weeks. From 5 dams for each group, 1–2 offspring for each dam were selected considering that each group can be composed of the same gender proportion in offspring. Finally, a total of eight offspring (4 males and 4 females) from each group were evaluated. Offspring were categorized into three groups as follows: control group, including offspring from the non-exposed group; 1 cigarette group, including offspring from the 1 cigarette exposed group; and 2 cigarette group, including offspring from the 2 cigarette exposed group. At 4 weeks, offspring from each dam were anaesthetized with isoflurane. The fourth lumbar vertebral body from each mouse was scanned by using a SkyScan1173 micro-CT apparatus (SkyScan, Kontich, Belgium) with an isotropic resolution of 18 µm. Micro-CT scanning operating parameters were 50 kVp volts of X-rays, 500 µA of source current, and 250 ms exposure. A 0.5-mm thick aluminum filter was used to minimize beam-hardening artifacts. During scanning, the lumbar spine was enclosed in a tightly fitting rigid plastic tube to prevent movement. The scans were taken in the distal transverse plane of the vertebral body for a 2.4-mm thick region. The number of slices was determined according to the size of the vertebrae and was approximately 200 slices per vertebral specimen. The 2-dimensional (2-D) grayscale CT images were reconstructed in 2,000×1,330 pixel matrices by using NRecon ver. 1.6.1.5 (SkyScan). Three-dimensional (3-D) reconstructions of Ø 0.61×0.71 mm of the trabecular bone on the central vertebral body were obtained from the same samples. Trabecular parameters including bone volume faction (bone volume/total volume, %), trabecular thickness (µm), separation (µm), and number (1/mm) were evaluated. The BMD (mg/cm3) was also measured.

4. Biochemical markers of bone turnover

Before obtaining micro-CT images, blood samples were collected from each offspring. To evaluate bone formation at the serum level, osteocalcin (OC) levels were measured by using a mouse OC enzyme-linked immunosorbent assay kit (Biomedical Technologies, Stoughton, MA, USA). To evaluate bone resorption at the serum level, C-terminal telopeptides of type I collagen (CTX) were measured by using the RatLaps™ enzyme immunoassay kit (Nordic Bioscience Diagnostics, Herlev, Denmark). The manufacturer's protocols were followed, and samples were assayed in duplicate. A standard curve was generated by using the provided protein and absolute concentrations from the kit, and the OC and CTX in the serum were extrapolated from a standard curve. Samples were measured at 450 nm for both the OC and CTX.

5. Statistics

Results are presented as the mean±standard deviation, and they were analyzed by using the Mann-Whitney U test. A P-value <0.05 was considered statistically significant.

Results

The number of pups from a non-exposed, 1 cigarette exposed and 2 cigarette exposed group were different (12.25±1.39, 11.25±0.46, and 12.50±0.54, P=0.027, respectively). The number of demise pups were also different among three groups with observation only in 2 cigarette exposed group (0, 0, and 0.75±0.46, P<0.001, respectively).
The BMD of the fourth lumbar vertebral body from each group was measured. BMD was significantly lower in the 2 cigarette group than in the control and 1 cigarette groups. However, no differences in BMD were observed between the control and 1 cigarette groups (Fig. 1).
The microarchitecture of the fourth lumbar vertebral body from each offspring was evaluated. Representative 2-D and 3- D micro-CT images of the fourth lumbar vertebral body from each group are presented in Fig. 2. The micro-CT images reveal that Perinatologythe 2 cigarette group had a smaller trabecular thickness, a decreased trabecular number, and expanded trabecular separation in the fourth lumbar vertebra compared to those in the control and 1 cigarette groups.
The results of microarchitecture analyses are presented in Fig. 3. Trabecular bone volume fraction, thickness, and number were significantly lower in the 2 cigarette group than in the control and 1 cigarette groups, whereas trabecular separation was higher in the 2 cigarette group than in the control group. However, no difference in trabecular separation was detected between the 1 and 2 cigarette groups. Trabecular bone volume fraction, thickness, number, and separation did not differ between the control and 1 cigarette groups.
The biochemical characteristics of bone turnover were compared between the three groups. There was a significant increase of serum CTX levels in the 2 cigarette group compared with those in the control and 1-cigarette group (Fig. 4). However, no difference in serum levels was observed between the control and 1 cigarette groups (Fig. 4). Serum OC levels were higher in the 1 and 2 cigarette groups compared with those in the control group. Serum OC levels were higher in the 1 cigarette group than in 2 cigarette group (Fig. 4).

Discussion

The present study evaluated the effect of maternal smoking during pregnancy on the bones of the offspring, and the results showed that maternal smoking during pregnancy is associated with a decrease in the offspring's BMD. This result is in line with the results of previous human and animal studies, which reported that maternal smoking during pregnancy has a negative effect on the offspring's bone growth.910
BMD is the chief parameter for diagnosing osteoporosis, evaluating bone characteristics, and predicting fracture risk; BMD is known to be responsible for approximately 70–80% of the strength in bone tissue.12 Although these characteristics are related to the mechanical performance of bones, their usefulness for predicting fracture risk is limited.13 For example, 50% of individuals presenting with hip fracture have a T-score above −2.5.14 Therefore, other factors in addition to BMD need to be evaluated to determine bone health. Bone microarchitecture properties are emerging as major determinants of the risk of fracture.1516 Bone microarchitecture significantly influences bone strength, independent of the BMD.17
Several animal studies have evaluated the effects of smoking on bone microarchitecture during various stages of life and reported that smoking has a negative influence on bone microarchitecture.1218 However, little is known about the effect of maternal smoking on the offspring's bone microarchitecture. In the present study, we evaluated the effect of maternal smoking during pregnancy on bone microarchitecture in the offspring, and found that maternal smoking during pregnancy was associated with deterioration of the bone microarchitecture of the offspring. Although several studies did not report any significant differences in bone mineral content and BMD between the infants of women who smoked and those of women who did not smoke,11 maternal smoking may have a detrimental effect on the offspring's bone through its effect on the microarchitecture.
The mechanism by which maternal smoking during pregnancy affects the offspring's bones is unclear, although there are several possible explanations. First, maternal smoking during pregnancy may have a direct effect on the offspring's bones. In our study, the levels of CTX, a bone resorption marker synthesized by osteoclasts, were higher in the cigarette-smoking groups. Smoking induces bone loss by increasing bone resorption.192021 Similarly, in the present study, maternal smoking during pregnancy may have increased bone resorption in the fetus, resulting in a decrease in the BMD and damage to the microarchitecture.
Another possible mechanism is that maternal smoking during pregnancy may indirectly affect fetal bones. For example, maternal smoking during pregnancy is related to the offspring's low birth weight222324 through a decrease in protein-like maternal energy intake2324 or through changes in the placenta and its vascularization leading to changes in placental morphology.25 Birth weight is associated with peak bone mass.26 Several studies reported that low birth weight is associated with lower BMD and the bone mineral content measured in various stages of life.272829 Recently, a meta-analysis confirmed that birth weight positively influences bone health in later life.30 Therefore, factors such as smoking during pregnancy that causes poor intrauterine growth may eventually have negative effects on the growth of the skeletal system, increasing lower bone mass and the risk of hip fracture from then on to adulthood. However, more research is needed to elucidate the mechanism underlying the effect of maternal smoking on the offspring's bones.
Given that smoking reduces the activity of osteoblasts through various pathways,21 we hypothesized that maternal smoking during pregnancy may negatively affect osteoblasts, resulting in a decrease in OC levels. In addition, infants of smoker women have significantly lower OC levels in the umbilical cord than that of infants of both passive smokers and nonsmoker women.31 In the present study, the levels of OC increased in the cigarette smoking groups. Although the reason for this discrepancy is unclear, there are possible explanations. Bones are dynamic organs; homeostasis is maintained because of the balance between bone resorption by osteoclasts and bone formation by osteoblasts. Therefore, an increase in the activity of osteoclasts caused by smoking may simulate the activity of osteoblasts to compensate and maintain bone homeostasis, resulting in an increase of OC levels. Another possible reason is related to the study design including the dose of smoking. Nicotine, one of the main effective ingredients contributing to the harmful effects of smoking, affects the proliferation of osteoblast cells and the expression of markers of bone formation.32 However, nicotine at lower concentrations stimulates bone formation, whereas at higher concentrations, it inhibits bone formation.3233 Similarly, in the present study, OC levels were higher in the cigarette groups, especially in the 1 cigarette group compared with the 2 cigarette group. Therefore, the dose of smoking used in this study may have stimulated bone formation. To confirm these dose-dependent effects of maternal smoking on bone formation, we used a 3 cigarette smoke exposed model; however, most fetuses aborted and the data could not be included (data not shown).
In the present study, we selected adolescence, which is the period during which a young person develops from a child into an adult, as the period to conduct the research by using 4-week-old mice.34 Therefore, further studies are needed to determine the long-term effects of maternal smoking during pregnancy on the offspring's bones. However, after the adolescence period, different factors such as food and exercise can influence bone characteristics in adulthood. Therefore, experiments performed before adolescence may more accurately reflect the effect of maternal smoking on the bones of the offspring.
In conclusion, maternal smoking during pregnancy was shown to have a negative effect on bone health in the offspring. These results are important to emphasize the importance of quitting smoking during pregnancy.

Figures and Tables

Fig. 1

The characteristics of the bone mineral density (BMD) of the fourth lumbar vertebral body from the control, 1 cigarette, and 2 cigarette groups (n=8 for each group). *P<0.05.

pn-29-114-g001
Fig. 2

Representative 2-dimensional (A–F) and 3-dimensional (G–I) micro-computed tomography images of the fourth lumbar vertebral body from the control (A, D, G), 1 cigarette (B, E, H), and 2 cigarette (C, F, I) groups.

pn-29-114-g002
Fig. 3

The characteristics of the microarchitecture of the fourth lumbar vertebral body from the control, 1 cigarette, and 2 cigarette groups (n=8 for each group). Bone volume fraction (A), trabecular thickness (B), number (C) and separation (D). *P<0.05.

pn-29-114-g003
Fig. 4

The biochemical characteristics of bone turnover in the control, 1 cigarette, and 2 cigarette groups (n=8 for each group). CTX, C-terminal telopeptides of type I collagen. OC, osteocalcin. *P<0.05.

pn-29-114-g004

Acknowledgments

This work was supported by a Korea University Grant (K1221061).

References

1. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q. 1992; 70:81–125.
crossref
2. Tsevat J. Impact and cost-effectiveness of smoking interventions. Am J Med. 1992; 93:43S–47S.
crossref
3. Daniell HW. Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med. 1976; 136:298–304.
crossref
4. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med. 1994; 330:387–392.
crossref
5. Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res. 1999; 14:215–220.
crossref
6. Tong VT, Dietz PM, Morrow B, D'Angelo DV, Farr SL, Rockhill KM, et al. Trends in smoking before, during, and after pregnancy--Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010. MMWR Surveill Summ. 2013; 62:1–19.
7. Jhun HJ, Seo HG, Lee DH, Sung MW, Kang YD, Syn HC, et al. Self-reported smoking and urinary cotinine levels among pregnant women in Korea and factors associated with smoking during pregnancy. J Korean Med Sci. 2010; 25:752–757.
crossref
8. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004; 6:Suppl 2. S125–S140.
crossref
9. Godfrey K, Walker-Bone K, Robinson S, Taylor P, Shore S, Wheeler T, et al. Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res. 2001; 16:1694–1703.
crossref
10. Jones G, Riley M, Dwyer T. Maternal smoking during pregnancy, growth, and bone mass in prepubertal children. J Bone Miner Res. 1999; 14:146–151.
crossref
11. Venkataraman PS, Duke JC. Bone mineral content of healthy, full-term neonates. Effect of race, gender, and maternal cigarette smoking. Am J Dis Child. 1991; 145:1310–1312.
12. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, et al. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res. 2001; 16:1195–1206.
crossref
13. Rodrigues AM, Caetano-Lopes J, Vale AC, Aleixo I, Pena AS, Faustino A, et al. Smoking is a predictor of worse trabecular mechanical performance in hip fragility fracture patients. J Bone Miner Metab. 2012; 30:692–699.
crossref
14. Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34:195–202.
crossref
15. Bouxsein ML, Karasik D. Bone geometry and skeletal fragility. Curr Osteoporos Rep. 2006; 4:49–56.
crossref
16. Grampp S, Lang P, Jergas M, Glüer CC, Mathur A, Engelke K, et al. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: short-term precision in vivo and comparison to dual X-ray absorptiometry. J Bone Miner Res. 1995; 10:1566–1576.
crossref
17. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res. 2000; 15:13–19.
crossref
18. Akhter MP, Lund AD, Gairola CG. Bone biomechanical property deterioration due to tobacco smoke exposure. Calcif Tissue Int. 2005; 77:319–326.
crossref
19. Ma D, Li Y, Hackfort B, Zhao Y, Xiao J, Swanson PC, et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. J Proteome Res. 2012; 11:3548–3560.
crossref
20. Gao SG, Li KH, Xu M, Jiang W, Shen H, Luo W, et al. Bone turnover in passive smoking female rat: relationships to change in bone mineral density. BMC Musculoskelet Disord. 2011; 12:131.
crossref
21. Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int. 2012; 23:2081–2092.
crossref
22. Heinz-Erian P, Spitzmüller A, Schröcksnadel H, Birnbacher R. Maternal smoking and inhibition of fetal growth factor. JAMA. 1998; 279:1954.
crossref
23. Haste FM, Brooke OG, Anderson HR, Bland JM. The effect of nutritional intake on outcome of pregnancy in smokers and non-smokers. Br J Nutr. 1991; 65:347–354.
crossref
24. D'Souza SW, Black P, Richards B. Smoking in pregnancy: associations with skinfold thickness, maternal weight gain, and fetal size at birth. Br Med J (Clin Res Ed). 1981; 282:1661–1663.
25. Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD, Page KR. A quantitative study on the effects of maternal smoking on placental morphology and cadmium concentration. Placenta. 2000; 21:247–256.
crossref
26. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M. Review: developmental origins of osteoporotic fracture. Osteoporos Int. 2006; 17:337–347.
crossref
27. Hovi P, Andersson S, Järvenpää AL, Eriksson JG, Strang-Karlsson S, Kajantie E, et al. Decreased bone mineral density in adults born with very low birth weight: a cohort study. PLoS Med. 2009; 6:e1000135.
crossref
28. Beltrand J, Alison M, Nicolescu R, Verkauskiene R, Deghmoun S, Sibony O, et al. Bone mineral content at birth is determined both by birth weight and fetal growth pattern. Pediatr Res. 2008; 64:86–90.
crossref
29. Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C. Intrauterine programming of adult body composition. J Clin Endocrinol Metab. 2001; 86:267–272.
crossref
30. Martínez-Mesa J, Restrepo-Méndez MC, González DA, Wehrmeister FC, Horta BL, Domingues MR, et al. Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis. Osteoporos Int. 2013; 24:7–18.
crossref
31. Colak O, Alataş O, AydoXğdu S, Uslu S. The effect of smoking on bone metabolism: maternal and cord blood bone marker levels. Clin Biochem. 2002; 35:247–250.
32. Fang MA, Frost PJ, Iida-Klein A, Hahn TJ. Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells. Bone. 1991; 12:283–286.
crossref
33. Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R. Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab. 2009; 27:555–561.
crossref
34. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ. Genetic variability in adult bone density among inbred strains of mice. Bone. 1996; 18:397–403.
crossref
TOOLS
Similar articles